This bill amends existing New Jersey law to include sickle cell anemia as a qualifying medical condition for the medical use of cannabis. The addition of sickle cell anemia recognizes the chronic pain and other symptoms associated with this inherited blood disorder, allowing patients suffering from it to access medical cannabis as a treatment option.

The bill specifically modifies the definition of "qualifying medical condition" to incorporate sickle cell anemia, thereby expanding the scope of conditions eligible for medical cannabis treatment. This change aims to improve the quality of life for patients with sickle cell anemia by providing them with an alternative therapeutic option to manage their symptoms effectively. The bill is set to take effect immediately upon enactment.

Statutes affected:
Introduced: 24:6I-3